openPR Logo
Press release

Whole Exome Sequencing Market Is Anticipated To Grow Up To USD 7.4 Billion By 2032 | Procter & Gamble , Unilever Group , Henkel AG

12-04-2023 03:13 AM CET | Health & Medicine

Press release from: Global Insight Services

The global Whole Exome Sequencing Market was valued at USD 1.4 Billion in 2022 and it is anticipated to grow up to USD 7.4 Billion by 2032, at a CAGR of 18.1% during the forecast period.

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10515/?utm_source=pranalipawar&utm_medium=Openpr&utm_campaign=04122023

Exome sequencing is a method for sequencing a genomes whole-exome and protein-coding genes. This method entails selecting the DNA segments that code for proteins or exons, then sequencing the exonic DNA with high-throughput DNA sequencing technologies. Exome sequencing is a technique for identifying genetic variations that cause disorders like Miller Syndrome and Alzheimers disease.

Market Trends and Drivers

The rising applications in clinical diagnostics, high demand for the diagnosis of rare diseases, expanding R&D in the field of genomics, next-generation sequencing, and increasing need for customized medicine are the key factors driving the global Whole Exome Sequencing Market. The total market is being driven by growth in the acceptability of next-generation sequencing approaches for the prediction, treatment, and monitoring of a variety of chronic diseases, such as cancer. The total market is being driven by growth in the acceptability of next-generation sequencing approaches for the prediction, treatment, and monitoring of a variety of chronic diseases, such as cancer. Some of the primary driving reasons for the worldwide Whole Exome Sequencing Market include the cheap costs and increased speed associated with whole-exome sequencing techniques, technological improvements in whole-exome sequencing techniques, and global partnerships among prominent research institutes..

Major Players in the Global Whole Exome Sequencing Market

The key players in the Whole Exome Sequencing Market are Ambry Genetics Corp. Bio-Rad Laboratories Inc., Eurofins Scientific Group, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Boston Scientific Corporation, QIAGEN, OraSure Technologies, Inc., Thermo Fisher Scientific, Helix OpCo, LLC., among others.

Report Overview- https://www.globalinsightservices.com/reports/whole-exome-sequencing-market//?utm_source=pranalipawar&utm_medium=Openpr&utm_campaign=04122023

COVID-19 Impact:

The outbreak of the COVID-19 pandemic pushed the pharmaceutical industry into action, with a race to develop therapeutic and preventive interventions. The onset of the SARS-CoV-2 pandemic set many pharmaceutical companies to quickly add clinical sequencing to expand safety testing that helped fight against the COVID-19 pandemic. COVID-19 had a significant impact on the whole exome sequencing market. For instance, as per the study published in PLOS ONE in January 2022, it was concluded that COVID-19 syndrome caused significant alterations in the blood transcriptome, which were assessed using RNAseq and verified using digital droplet PCR (ddPCR) on specific targets. Such studies augment the use of whole exome sequencing in analyzing the progression of COVID-19, thereby boosting the market's growth over the coming years. Hence, owing to the increasing RNA and DNA sequencing-based research & development activities in developing diagnostic tools or effective therapeutics for COVID-19, the market is likely to continue its significant growth rate during the forecast period.

Speak to Analyst for more details https://www.globalinsightservices.com/request-customization/GIS10515/?utm_source=pranalipawar&utm_medium=Openpr&utm_campaign=04122023

Global Whole Exmore Sequencing Market Segmentation

By Product

System
Kits
Services

By Technology

Second-Generation Sequencing
Third-Generation Sequencing

By Application

Diagnostics
Drug Discovery and Development
Personalized Medicine
Others

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10515/?utm_source=pranalipawar&utm_medium=Openpr&utm_campaign=04122023

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Whole Exome Sequencing Market Is Anticipated To Grow Up To USD 7.4 Billion By 2032 | Procter & Gamble , Unilever Group , Henkel AG here

News-ID: 3313166 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Sequencing

Sequencing Reagents Market Report 2024 - Sequencing Reagents Market Trends And S …
"The Business Research Company recently released a comprehensive report on the Global Sequencing Reagents Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Sequencing the Future: Next Generation Sequencing Market Projections (2023-2033)
The global Next-generation Sequencing Market was over 8.5 billion in 2022 and it is anticipated to grow at a CAGR of over 18.2% during the forecast period. Market Outlook: The Next Generation Sequencing (NGS) market is set for an extraordinary trajectory of growth and innovation from 2023 to 2033. This decade is poised to witness a paradigm shift in genomics and molecular biology, with NGS technologies playing a central role in reshaping
Sequencing Reagents Market - Elevating Accuracy, Inspiring Discovery: Revolution …
Newark, New Castle, USA - new report, titled Sequencing Reagents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sequencing Reagents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sequencing Reagents market. The report offers an overview of the market, which
Microbiome Sequencing Services Market By Technology (Sequencing By Synthesis (SB …
Microbiome are the group of microorganisms that grow on saliva, skin layers, conjunctiva, oral mucosa and the gastrointestinal tract. Microbiome sequencing is the study and analysis of microbes groups located outside and inside of the human body to gain knowledge about human microbes. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00004419/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: Baseclear B.V. Clinical-Microbiomics A/S Molzym GmbH & Co. Kg Zymo Research Corp. Rancho Biosciences Microbiome Therapeutics, LLC. Microbiome Insights Inc. Openbiome Resphera Biosciences, LLC. Ubiome, Inc. The report covers key developments
Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com Get Research Sample PDF at https://www.search4research.com/request-sample/113582/ Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period. Metagenomics, is a field where genomic analysis of microbial DNA